Annexon Inc (ANNX)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-18 | S Sale |
EVP & CHIEF INNOVATION OFFICER Officer |
8,345
-12.0%
2.91USD 24,284 |
8,345 -12.0% | 2.91 | USD 24,284 | |
| 2025-02-20 | 2025-02-18 | S Sale |
EVP & CHIEF BUSINESS OFFICER Officer |
6,618
-7.1%
2.95USD 19,523 |
6,618 -7.1% | 2.95 | USD 19,523 | |
| 2025-02-20 | 2025-02-18 | S Sale |
CHIEF MEDICAL OFFICER Officer |
5,521
-14.2%
2.96USD 16,342 |
5,521 -14.2% | 2.96 | USD 16,342 | |
| 2025-02-20 | 2025-02-18 | S Sale |
EVP & CHIEF SCIENTIFIC OFFICER Officer |
5,515
-6.2%
2.97USD 16,380 |
5,515 -6.2% | 2.97 | USD 16,380 | |
| 2025-02-20 | 2025-02-18 | S Sale |
EVP & CHIEF FINANCIAL OFFICER Officer |
6,912
-8.2%
2.92USD 20,183 |
6,912 -8.2% | 2.92 | USD 20,183 | |
| 2025-02-18 | 2025-02-13 | S Sale |
EVP & CHIEF BUSINESS OFFICER Officer |
1,425
-1.5%
2.99USD 4,261 |
1,425 -1.5% | 2.99 | USD 4,261 | |
| 2025-02-18 | 2025-02-13 | S Sale |
EVP & CHIEF FINANCIAL OFFICER Officer |
1,786
-2.1%
2.98USD 5,322 |
1,786 -2.1% | 2.98 | USD 5,322 | |
| 2025-02-18 | 2025-02-13 | S Sale |
PRESIDENT AND CEO Executive Director |
5,021
-1.4%
2.95USD 14,812 |
5,021 -1.4% | 2.95 | USD 14,812 | |
| 2025-02-18 | 2025-02-13 | S Sale |
EVP & CHIEF INNOVATION OFFICER Officer |
1,783
-2.5%
2.99USD 5,331 |
1,783 -2.5% | 2.99 | USD 5,331 | |
| 2024-12-04 | 2024-12-02 | PP Planned purchase | Non-Executive Director |
3,200
+14.3%
5.33USD 17,056 |
3,200 +14.3% | 5.33 | USD 17,056 | |
| 2024-10-17 | 2024-10-15 | PS Planned sale |
EVP & CHIEF INNOVATION OFFICER Officer |
5,408
-7.0%
7.41USD 40,073 |
5,408 -7.0% | 7.41 | USD 40,073 | |
| 2024-10-02 | 2024-10-01 | PP Planned purchase | Non-Executive Director |
3,200
+16.7%
5.97USD 19,104 |
3,200 +16.7% | 5.97 | USD 19,104 | |
| 2024-09-20 | 2024-09-19 | PS Planned sale |
EVP & CHIEF INNOVATION OFFICER Officer |
4,500
-100.0%
7.10USD 31,950 |
4,500 -100.0% | 7.10 | USD 31,950 | |
| 2024-09-16 | 2024-09-12 | PS Planned sale |
EVP & CHIEF INNOVATION OFFICER Officer |
5,500
-55.0%
6.16USD 33,880 |
5,500 -55.0% | 6.16 | USD 33,880 | |
| 2024-09-06 | 2024-09-05 | PS Planned sale |
EVP & CHIEF INNOVATION OFFICER Officer |
5,500
-35.5%
5.64USD 31,020 |
5,500 -35.5% | 5.64 | USD 31,020 | |
| 2024-09-04 | 2024-09-03 | PP Planned purchase | Non-Executive Director |
3,200
+20.0%
5.48USD 17,536 |
3,200 +20.0% | 5.48 | USD 17,536 | |
| 2024-08-30 | 2024-08-29 | PS Planned sale |
EVP & CHIEF INNOVATION OFFICER Officer |
5,500
-26.2%
5.95USD 32,725 |
5,500 -26.2% | 5.95 | USD 32,725 | |
| 2024-08-05 | 2024-08-01 | PP Planned purchase | Non-Executive Director |
3,200
+25.0%
6.24USD 19,968 |
3,200 +25.0% | 6.24 | USD 19,968 | |
| 2024-07-17 | 2024-07-15 | S Sale |
EVP & CHIEF INNOVATION OFFICER Officer |
1,106
-1.5%
6.02USD 6,658 |
1,106 -1.5% | 6.02 | USD 6,658 | |
| 2024-07-17 | 2024-07-15 | PS Planned sale |
EVP & CHIEF FINANCIAL OFFICER Officer |
1,104
-1.3%
6.03USD 6,657 |
1,104 -1.3% | 6.03 | USD 6,657 | |
| 2024-07-17 | 2024-07-15 | PS Planned sale |
EVP & CHIEF BUSINESS OFFICER Officer |
784
-0.8%
6.02USD 4,720 |
784 -0.8% | 6.02 | USD 4,720 | |
| 2024-07-02 | 2024-07-01 | PP Planned purchase | Non-Executive Director |
3,200
+33.3%
5.00USD 16,000 |
3,200 +33.3% | 5.00 | USD 16,000 | |
| 2024-06-05 | 2024-06-03 | PP Planned purchase | Non-Executive Director |
3,200
+50.0%
4.83USD 15,459 |
3,200 +50.0% | 4.83 | USD 15,459 | |
| 2024-05-03 | 2024-05-01 | PP Planned purchase | Non-Executive Director |
3,200
+100.0%
4.68USD 14,982 |
3,200 +100.0% | 4.68 | USD 14,982 | |
| 2024-05-03 | 2024-05-01 | PP Planned purchase | Non-Executive Director |
3,200
+100.0%
4.68USD 14,982 |
3,200 +100.0% | 4.68 | USD 14,982 | |
| 2024-04-10 | 2024-04-08 | PP Planned purchase | Non-Executive Director |
3,200
+inf%
6.07USD 19,411 |
3,200 +inf% | 6.07 | USD 19,411 | |
| 2024-02-21 | 2024-02-20 | S Sale |
EVP & CHIEF FINANCIAL OFFICER Officer |
2,593
-3.1%
5.53USD 14,339 |
2,593 -3.1% | 5.53 | USD 14,339 | |
| 2024-02-21 | 2024-02-20 | S Sale |
EVP & CHIEF BUSINESS OFFICER Officer |
1,951
-2.2%
5.48USD 10,691 |
1,951 -2.2% | 5.48 | USD 10,691 | |
| 2024-02-21 | 2024-02-20 | S Sale |
EVP & CHIEF INNOVATION OFFICER Officer |
2,604
-3.5%
5.51USD 14,348 |
2,604 -3.5% | 5.51 | USD 14,348 | |
| 2024-02-14 | 2024-02-12 | S Sale |
EVP & CHIEF FINANCIAL OFFICER Officer |
1,809
-3.8%
5.54USD 10,022 |
1,809 -3.8% | 5.54 | USD 10,022 | |
| 2024-02-14 | 2024-02-12 | PS Planned sale |
PRESIDENT AND CEO Executive Director |
5,782
-2.9%
5.54USD 32,032 |
5,782 -2.9% | 5.54 | USD 32,032 | |
| 2024-02-14 | 2024-02-12 | S Sale |
EVP & CHIEF INNOVATION OFFICER Officer |
1,810
-4.8%
5.54USD 10,027 |
1,810 -4.8% | 5.54 | USD 10,027 | |
| 2024-02-14 | 2024-02-12 | PS Planned sale |
EVP & CHIEF BUSINESS OFFICER Officer |
1,349
-2.7%
5.53USD 7,460 |
1,349 -2.7% | 5.53 | USD 7,460 | |
| 2023-12-29 | 2023-12-27 | PS Planned sale |
EVP & Chief Innovation Officer Officer |
21,000
-100.0%
4.52USD 94,966 |
21,000 -100.0% | 4.52 | USD 94,966 | |
| 2023-12-28 | 2023-12-26 | B Purchase | Non-Executive Director Large shareholder |
350,000
+5.0%
2.88USD 1,008,000 |
350,000 +5.0% | 2.88 | USD 1,008,000 | |
| 2024-01-23 | 2023-07-11 | S Sale |
EVP & Chief Financial Officer Officer |
1,057
-2.2%
3.84USD 4,055 |
1,057 -2.2% | 3.84 | USD 4,055 | |
| 2024-01-23 | 2023-07-11 | S Sale |
EVP & Chief Business Officer Officer |
978
-2.1%
3.84USD 3,752 |
978 -2.1% | 3.84 | USD 3,752 | |
| 2023-05-30 | 2023-05-25 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
300,000
+5.6%
2.13USD 639,720 |
300,000 +5.6% | 2.13 | USD 639,720 | |
| 2023-02-17 | 2023-02-15 | PS Planned sale |
President & CEO Executive Director |
6,571
-3.2%
5.87USD 38,564 |
6,571 -3.2% | 5.87 | USD 38,564 | |
| 2023-02-15 | 2023-02-14 | S Sale |
EVP & Chief Business Officer Officer |
144
-0.5%
6.30USD 907 |
144 -0.5% | 6.30 | USD 907 | |
| 2023-02-15 | 2023-02-14 | S Sale |
EVP & Chief Financial Officer Officer |
166
-0.6%
6.30USD 1,046 |
166 -0.6% | 6.30 | USD 1,046 | |
| 2023-02-15 | 2023-02-13 | PS Planned sale |
EVP & Chief Business Officer Officer |
1,501
-5.1%
6.30USD 9,461 |
1,501 -5.1% | 6.30 | USD 9,461 | |
| 2023-02-15 | 2023-02-13 | PS Planned sale |
EVP & Chief Financial Officer Officer |
1,742
-5.5%
6.31USD 10,989 |
1,742 -5.5% | 6.31 | USD 10,989 | |
| 2023-02-14 | 2023-02-10 | B Purchase | Non-Executive Director Large shareholder |
2,647,058
+60.0%
6.80USD 17,999,994 |
2,647,058 +60.0% | 6.80 | USD 17,999,994 | |
| 2022-07-11 | 2022-07-07 | B Purchase | Non-Executive Director |
2,453,988
+125.5%
3.84USD 9,423,314 |
2,453,988 +125.5% | 3.84 | USD 9,423,314 | |
| 2022-04-18 | 2022-04-14 | B Purchase |
President & CEO Executive Director |
60,000
+42.6%
2.45USD 146,814 |
60,000 +42.6% | 2.45 | USD 146,814 | |
| 2021-06-09 | 2021-06-08 | PS Planned sale |
President & CEO Executive Director |
3,750
-100.0%
22.55USD 84,563 |
3,750 -100.0% | 22.55 | USD 84,563 | |
| 2021-06-09 | 2021-06-07 | PS Planned sale |
President & CEO Executive Director |
3,750
-100.0%
22.31USD 83,667 |
3,750 -100.0% | 22.31 | USD 83,667 | |
| 2021-06-07 | 2021-06-03 | PS Planned sale |
EVP & Chief Scientific Officer Officer |
2,184
-100.0%
21.72USD 47,441 |
2,184 -100.0% | 21.72 | USD 47,441 | |
| 2021-06-07 | 2021-06-03 | PS Planned sale |
EVP & Chief Scientific Officer Officer |
12,816
-85.4%
21.45USD 274,884 |
12,816 -85.4% | 21.45 | USD 274,884 | |
| 2021-06-01 | 2021-05-27 | PS Planned sale |
EVP & Chief Financial Officer Officer |
3,500
-63.6%
22.24USD 77,835 |
3,500 -63.6% | 22.24 | USD 77,835 | |
| 2021-04-02 | 2021-04-01 | PS Planned sale |
President & CEO Executive Director |
300
-100.0%
28.01USD 8,403 |
300 -100.0% | 28.01 | USD 8,403 | |
| 2021-04-02 | 2021-04-01 | PS Planned sale |
President & CEO Executive Director |
200
-40.0%
28.19USD 5,638 |
200 -40.0% | 28.19 | USD 5,638 | |
| 2021-04-02 | 2021-03-31 | PS Planned sale |
President & CEO Executive Director |
7,102
-100.0%
28.11USD 199,621 |
7,102 -100.0% | 28.11 | USD 199,621 | |
| 2021-03-29 | 2021-03-25 | PS Planned sale |
EVP & Chief Scientific Officer Officer |
237
-100.0%
29.96USD 7,101 |
237 -100.0% | 29.96 | USD 7,101 | |
| 2021-03-29 | 2021-03-25 | PS Planned sale |
EVP & Chief Scientific Officer Officer |
5,680
-96.0%
29.21USD 165,914 |
5,680 -96.0% | 29.21 | USD 165,914 | |
| 2021-03-29 | 2021-03-25 | PS Planned sale |
EVP & Chief Scientific Officer Officer |
10,258
-63.4%
28.54USD 292,755 |
10,258 -63.4% | 28.54 | USD 292,755 | |
| 2021-03-26 | 2021-03-24 | PS Planned sale |
EVP & Chief Medical Officer Officer |
3,995
-100.0%
30.17USD 120,512 |
3,995 -100.0% | 30.17 | USD 120,512 | |
| 2021-03-25 | 2021-03-23 | PS Planned sale |
EVP & Chief Financial Officer Officer |
1,800
-47.4%
29.16USD 52,493 |
1,800 -47.4% | 29.16 | USD 52,493 | |
| 2021-03-25 | 2021-03-23 | PS Planned sale |
EVP & Chief Financial Officer Officer |
1,800
-32.1%
28.43USD 51,175 |
1,800 -32.1% | 28.43 | USD 51,175 | |
| 2021-03-25 | 2021-03-23 | PS Planned sale |
EVP & Chief Financial Officer Officer |
1,400
-20.0%
27.51USD 38,509 |
1,400 -20.0% | 27.51 | USD 38,509 | |
| 2020-07-30 | 2020-07-28 | B Purchase | Large shareholder |
200,000
+7.9%
17.00USD 3,400,000 |
200,000 +7.9% | 17.00 | USD 3,400,000 | |
| 2020-07-28 | 2020-07-28 | B Purchase | Large shareholder |
350,000
+76.3%
17.00USD 5,950,000 |
350,000 +76.3% | 17.00 | USD 5,950,000 | |
| 2020-07-28 | 2020-07-28 | B Purchase | Large shareholder |
350,000
+76.3%
17.00USD 5,950,000 |
350,000 +76.3% | 17.00 | USD 5,950,000 | |
| 2020-07-28 | 2020-07-28 | B Purchase | Non-Executive Director |
200,000
+11.4%
17.00USD 3,400,000 |
200,000 +11.4% | 17.00 | USD 3,400,000 | |
| 2020-07-28 | 2020-07-28 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
400,000
+14.1%
17.00USD 6,800,000 |
400,000 +14.1% | 17.00 | USD 6,800,000 | |
| 2020-07-28 | 2020-07-28 | B Purchase |
EVP & Chief Financial Officer Officer |
2,000
+inf%
17.00USD 34,000 |
2,000 +inf% | 17.00 | USD 34,000 |